HealthCare Royalty Partners
  • Home
  • Approach
  • Team
  • Portfolio
  • News
  • Contact
  • Investor Login

NEWS

May 12, 2020

COVID-19 Private Financing

Full Article

April 8, 2020

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

Full Article

April 2, 2020

RedHill Biopharma Completes Acquisition of Movantik® from AstraZeneca

Full Article

March 2, 2020

Karyopharm Announces Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Multiple Myeloma Following One to Three Prior Lines of Therapy

Full Article

February 25, 2020

RedHill Biopharma Acquires Rights to Movantik® from AstraZeneca

Full Article

February 25, 2020

RedHill Biopharma Enters $115 Million Non-Dilutive Financing Agreement with HealthCare Royalty Partners

Full Article

January 9, 2020

HealthCare Royalty Partners Raises $1.8 Billion

Full Article

October 25, 2019

GSK receives prestigious Prix Galien USA award for SHINGRIX

Full Article

September 16, 2019

Karyopharm Enters Into Royalty Agreement with Healthcare Royalty Partners for up to $150 Million

Full Article

March 6, 2019

Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA™ for $30 Million Gross Proceeds

Full Article

Previous

Page 2 of 13

Next

  • APPROACH
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • INVESTOR LOGIN

LinkedIn Copyright © 2021 HealthCare Royalty Partners | Disclaimer